arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

SURO CAPITAL CORP.

SSSS

$12.56 0.00 (0.00%) at close

20 Visible periods

10 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, SURO CAPITAL CORP. shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $326.3M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC —

FCF / Share $-0.93 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Jun 30, 2026.

20-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$155.64M

— 0.0% —

FCF / Share Free cash flow per share

$-0.93

↓ -308.8% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.70x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗
EPS Growth YoY (%)	N/M	N/M	-8700.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	96.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	97.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	25.0% Good Good Year-over-year change in earnings per share Optimal: > 10%	N/M	29.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	80.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-75.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	31.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	N/M	96.3% Excellent → Excellent Stable Year-over-year change in net income	96.3% Excellent Excellent Year-over-year change in net income	96.3% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	N/M	26.4% Excellent ↑ Excellent Improving Year-over-year change in net income	—	-77.4% Weak Weak Year-over-year change in net income	-77.4% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	N/M	-43.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	99.5% Excellent Excellent Year-over-year change in free cash flow	156.7% Excellent Excellent Year-over-year change in free cash flow	N/M	—	N/M	—	213.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	237.1% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗
FCF / Net Income (x)	-0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.04x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.22x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-41.82x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	4.61x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-279.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	-0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.03x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	4.96x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	10.75x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.76x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.04x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	—	-0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.07x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

📊 What does each share earn? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗
Basic EPS, GAAP (USD)	$-0.72	$6.13	$-0.88	$0.30	$2.63	$-0.03	$-0.01	$-0.23	$-0.45	$-0.87	$-0.34	$0.99	$-0.60	$0.16	$-0.48	$-1.54	$-3.08	$0.66	$-0.70	$0.55
Free Cash Flow per Share (USD)	$-0.93	$-0.23	—	$-0.00	$1.42	$-0.16	—	$-0.89	$0.55	$0.90	—	$1.96	—	$0.29	—	—	$-0.31	$-0.04	—	—
Basic Weighted Avg Shares (shares)	25.98M	25.38M	—	24.37M	23.73M	23.57M	—	23.38M	23.41M	25.39M	—	25.35M	25.95M	28.38M	—	29.78M	30.63M	31.23M	—	27.62M

📋 What is driving earnings? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗
Net Income, GAAP (USD)	$155.64M	$155.64M	$-20.13M	$-806.72K	$-806.72K	$-806.72K	$44.53K	$-22.07M	$-22.07M	$-22.07M	$-9.12M	$4.62M	$4.62M	$4.62M	$-12.39M	—	$20.46M	$20.46M	—	—
Operating Cash Flow (USD)	$-24.09M	$-5.76M	$4.40M	$-100.71K	$33.74M	$-3.72M	$-12.45M	$-20.89M	$12.97M	$22.74M	$-45.29M	$49.64M	—	$8.10M	$518.75K	—	$-9.56M	$-1.39M	$45.90M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 20 quarters

SURO CAPITAL CORP.

Analytical Summary

20-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare SSSS with peers